Terms: = Gastric cancer AND SDC4, ENSG00000124145, 6385, P31431, SYND4, MGC22217
5 results:
1. Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival.
Poças J; Marques C; Gomes C; Otake AH; Pinto F; Ferreira M; Silva T; Faria-Ramos I; Matos R; Ribeiro AR; Senra E; Cavadas B; Batista S; Maia J; Macedo JA; Lima L; Afonso LP; Ferreira JA; Santos LL; Polónia A; Osório H; Belting M; Reis CA; Costa-Silva B; Magalhães A
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2214853120. PubMed ID: 37155874
[TBL] [Abstract] [Full Text] [Related]
2. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological Outcomes of Patients with Early gastric cancer after Non-Curative Endoscopic Submucosal Dissection.
Hoteya S; Iizuka T; Kikuchi D; Ogawa O; Mitani T; Matsui A; Furuhata T; Yamashita S; Yamada A; Kaise M
Digestion; 2016; 93(1):53-8. PubMed ID: 26789628
[TBL] [Abstract] [Full Text] [Related]
4. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer.
Bae SJ; Ahn DH; Hong SP; Kang H; Hwang SG; Oh D; Kim NK
Yonsei Med J; 2008 Oct; 49(5):783-91. PubMed ID: 18972599
[TBL] [Abstract] [Full Text] [Related]
5. Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer.
Papa ML; Capasso F; Pudore L; Torre S; Mango S; Russo V; Delrio P; Palaia R; Ruffolo F; d'Eufemia MD; De Lucia D; Napolitano M; Di Micco P; Parisi V
Exp Oncol; 2007 Jun; 29(2):111-5. PubMed ID: 17704742
[TBL] [Abstract] [Full Text] [Related]
